{
    "nct_id": "NCT06026371",
    "official_title": "Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation",
    "inclusion_criteria": "* Age >= 18\n* Signed informed consent\n* Able to take oral medications\n* Planned T-replete allogeneic hematopoietic cell transplantation for any indication. History of prior transplantation is allowed\n* Planned GVHD prophylaxis using one of the following regimens:\n\n  * Calcineurin inhibitor (tacrolimus or cyclosporine) plus methotrexate\n  * Calcineurin inhibitor (tacrolimus or cyclosporine) plus mycophenolate mofetil (MMF)\n  * Sirolimus plus cyclosporine plus MMF\n  * Post-transplant cyclophosphamide plus calcineurin inhibitor (with or without MMF or sirolimus)\n* One of the following HCT donor types:\n\n  * Human leukocyte antigen (HLA)-matched sibling donor\n  * 9/10 or 10/10 HLA-matched unrelated donor\n  * HLA- haploidentical donor\n  * Cord blood\n* Willing to use at least 1 accepted method of contraception until day 180 after transplant and agree to not donate eggs/sperm for 180 days after\n* Not pregnant or breast feeding\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: Absolute neutrophil count (ANC) recovery to > 0.5 x 10^9/L from nadir, without ongoing growth factor support\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: Discontinuation of all antibacterial antibiotics (except those used for Pneumocystis jiroveci prophylaxis) for 2 days\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: Resolution of all acute toxicities (other than anemia and thrombocytopenia) to Common Terminology Criteria for Adverse Events (CTCAE) grade 2 or lower\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: Ability to swallow capsules\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: No grade II-IV acute GVHD\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: No moderate to severe chronic GVHD\n* ELIGIBILITY CRITERIA FOR RANDOMIZATION: No concurrent antibiotics to treat infections. Prophylactic antiviral and antifungal antibiotics used to prevent infections are allowed\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Severe food allergy in the form of anaphylaxis or attributable symptoms requiring hospitalization\n* History of chronic aspiration or conditions predisposing to aspiration (e.g. neuromuscular disorders)\n* Receiving or planned to receive other experimental agents (including ex vivo T-cell depletion) to prevent GVHD. The use of other experimental agents is prohibited unless approved by the principal investigator (PI) of the other trial",
    "miscellaneous_criteria": ""
}